Angra - Kseromaticsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-11
Share capital
400,000.00 PLN
Registered address
Heweliusza 7, 59-220 Legnica, Poland
Electronic delivery address
AE:PL-43055-41262-JIFBJ-26

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 318 days for 2021).

  • 2023not filed
  • 202224/10/2023
  • 202129/05/2023
  • 2020filed
  • 2019filed
  • 2018filed
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 385.76kMedianUSD 219.09kAverageUSD 219.09k
Net profit
This companyUSD -504.65MedianUSD -2.55kAverageUSD -2.55k
Operating costs
This companyUSD 386.25kMedianUSD 220.99kAverageUSD 220.99k
Assets
This companyUSD 429.50kMedianUSD 247.32kAverageUSD 247.32k

Public procurement

1 tender recorded as contractor, with a total value of $62,494.

SubjectAmount
Supply and implementation of computer equipment together with software
$62,494

Authorized Representatives

Aleksy Marian Ignaczak – President of the Management Board
Michał Marcin Ignaczak – Attorney-in-fact

Manner of representation

Each member of the management board is authorised to submit declarations of will and sign on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Aleksy Marian Ignaczakage 72
401$54,159.9150.125%
Michał Ignaczakage 43
399$53,889.7949.875%

Aleksy Marian Ignaczak and Michał Ignaczak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-12-04.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

8 public aid cases recorded, with a total value of $37,940.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$8,104
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,559
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,381

Competitors

Name
Wills Innovationsp. z o.o.
BioceltixS.A.
OrthogetS.A.
BiottsS.A.
MedisensonicS.A.
Green ZebrasS.A.
BiocamS.A.
Vitrotest Europesp. z o.o.
VASA Therapeuticssp. z o.o.
Nantes - Systemy Nanotechnologiisp. z o.o.

Change history

DateEvent
2006-08-24Share capital increase
2004-02-27Share capital increase
2001-07-11Entered in the register

FAQ

Last updated: 2026-04-01